scispace - formally typeset
F

Fabio Candotti

Researcher at National Institutes of Health

Publications -  170
Citations -  10647

Fabio Candotti is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Genetic enhancement & Severe combined immunodeficiency. The author has an hindex of 49, co-authored 153 publications receiving 9507 citations. Previous affiliations of Fabio Candotti include RMIT University & University Hospital of Lausanne.

Papers
More filters
Journal ArticleDOI

Activated STING in a Vascular and Pulmonary Syndrome

TL;DR: STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disease caused by gain-of-function mutations in TMEM173, the stimulator of interferon genes (STING), andConstitutive up-regulation of phosphorylated STAT1 in patients' lymphocytes was reduced by JAK inhibitors.
Journal ArticleDOI

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

TL;DR: Two unrelated T- B+SCID patients who have homozygous mutations in the gene for Jak-3 are investigated and abnormalities in the Jak/STAT signalling pathway can account for SCID in humans.
Journal ArticleDOI

Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

TL;DR: Loss-of-function mutations in CECR1 were associated with a spectrum of vascular and inflammatory phenotypes, ranging from early-onset recurrent stroke to systemic vasculopathy or vasculitis, and were prevented by coinjection with nonmutated (but not with mutated) human C ECR1.
Journal ArticleDOI

Engraftment potential of human amnion and chorion cells derived from term placenta

TL;DR: Human amnion and chorion cells from term placenta can successfully engraft neonatal swine and rats and are suggested to represent an advantageous source of progenitor cells with potential applications in a variety of cell therapy and transplantation procedures.